172 related articles for article (PubMed ID: 38611785)
1. Exploring Geometrical, Electronic and Spectroscopic Properties of 2-Nitroimidazole-Based Radiopharmaceuticals via Computational Chemistry Methods.
Crișan G; Stan Ș; Chiș V
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611785
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia imaging agents labeled with positron emitters.
Hoigebazar L; Jeong JM
Recent Results Cancer Res; 2013; 194():285-99. PubMed ID: 22918765
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three
Dos Santos SN; Wuest M; Jans HS; Woodfield J; Nario AP; Krys D; Dufour J; Glubrecht D; Bergman C; Bernardes ES; Wuest F
Nucl Med Biol; 2023; 124-125():108383. PubMed ID: 37651917
[TBL] [Abstract][Full Text] [Related]
4. Nitroimidazole radiopharmaceuticals in bioimaging: part I: synthesis and imaging applications.
Sharma R
Curr Radiopharm; 2011 Oct; 4(4):361-78. PubMed ID: 22202159
[TBL] [Abstract][Full Text] [Related]
5. β -[
Kumar P; Roselt P; Reischl G; Cullinane C; Beiki D; Ehrlichmann W; Binns D; Naimi E; Yang J; Hicks R; Machulla HJ; Wiebe LI
Curr Radiopharm; 2017; 10(2):93-101. PubMed ID: 28294075
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
[TBL] [Abstract][Full Text] [Related]
7. [Accumulation Mechanism of 2-Nitroimidazole-based Hypoxia Imaging Probes Revealed by Imaging Mass Spectrometry].
Shimizu Y
Yakugaku Zasshi; 2018; 138(11):1345-1352. PubMed ID: 30381642
[TBL] [Abstract][Full Text] [Related]
8. Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET: a review.
Halmos GB; Bruine de Bruin L; Langendijk JA; van der Laan BF; Pruim J; Steenbakkers RJ
Clin Nucl Med; 2014 Jan; 39(1):44-8. PubMed ID: 24152663
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances of
Nguyen AT; Kim HK
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445730
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [
Gammon ST; Pisaneschi F; Bandi ML; Smith MG; Sun Y; Rao Y; Muller F; Wong F; De Groot J; Ackroyd J; Mawlawi O; Davies MA; Gopal YNV; Di Francesco ME; Marszalek JR; Dewhirst M; Piwnica-Worms D
Cells; 2019 Nov; 8(12):. PubMed ID: 31766580
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
Wei Y; Zhao W; Huang Y; Yu Q; Zhu S; Wang S; Zhao S; Hu X; Yu J; Yuan S
PLoS One; 2016; 11(6):e0157606. PubMed ID: 27322586
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of [
Sun W; Falzon C; Naimi E; Akbari A; Wiebe LI; Tandon M; Kumar P
Curr Radiopharm; 2019; 12(1):49-57. PubMed ID: 30338747
[TBL] [Abstract][Full Text] [Related]
13. Insight into Tumor Hypoxia: Radionuclide-based Biomarker as Diagnostic Tools.
Saxena P; Gambhir S; Dixit M
Curr Top Med Chem; 2023; 23(12):1136-1154. PubMed ID: 37190811
[TBL] [Abstract][Full Text] [Related]
14. Imaging of tumor hypoxia to predict treatment sensitivity.
Minn H; Grönroos TJ; Komar G; Eskola O; Lehtiö K; Tuomela J; Seppänen M; Solin O
Curr Pharm Des; 2008; 14(28):2932-42. PubMed ID: 18991711
[TBL] [Abstract][Full Text] [Related]
15. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.
Lehtiö K; Oikonen V; Grönroos T; Eskola O; Kalliokoski K; Bergman J; Solin O; Grénman R; Nuutila P; Minn H
J Nucl Med; 2001 Nov; 42(11):1643-52. PubMed ID: 11696633
[TBL] [Abstract][Full Text] [Related]
16. Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).
Postema EJ; McEwan AJ; Riauka TA; Kumar P; Richmond DA; Abrams DN; Wiebe LI
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1565-73. PubMed ID: 19430784
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors.
Nguyen AT; Kim HK
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514026
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]